COPD Practice Questions for Exam
Question AND Answers
A 25 year old smoker with a 10 pack year history of smoking should be given what
counsel to prevent development of COPD?
*A.* Use albuterol as needed to prevent symptoms
*B.* Use ipratropium as needed to prevent symptoms
*C.* Need for an influenza vaccination
*D.* Smoking cessation information
*E.* All of the above - ✔ *D.* Smoking cessation information
The risk of theophylline toxicity is *MOST* likely to occur in a patient who has
discontinued:
*A.* Smoking
*B.* Omeprazole
*C.* Fluoxetine
*D.* Warfarin
*E.* Gentamicin - ✔ *A.* Smoking
JJ is a 65 yom who comes to the clinic today for his annual visit. While reviewing his
records you discover he has had 5 COPD exacerbations requiring hospitalization since
his last visit a year ago. The most recent event occurred two months ago. Spirometry
reveals a FEV1 of 29%. How should you classify this patient's COPD?
*A.* Group A
*B.* Group B
*C.* Group C
*D.* Group D - ✔ C, D (He didn't specify the the mMRC nor the CAT...)(I'm sure he was
going for D, but not sure)
A PDE-4 inhibitor is recommended as third choice in which of the following COPD
groups?
*A.* Group A
*B.* Group B
*C.* Group C
*D.* Group D - ✔ *C.* Group C (Slide 98)
Which of the following medications is recommended as third choice in all COPD
classes?
*A.* Ipratropium
*B.* Theophylline
*C.* Albuterol
*D.* Anoro Ellipta
*E.* Roflumilast - ✔ *B.* Theophylline
Question AND Answers
A 25 year old smoker with a 10 pack year history of smoking should be given what
counsel to prevent development of COPD?
*A.* Use albuterol as needed to prevent symptoms
*B.* Use ipratropium as needed to prevent symptoms
*C.* Need for an influenza vaccination
*D.* Smoking cessation information
*E.* All of the above - ✔ *D.* Smoking cessation information
The risk of theophylline toxicity is *MOST* likely to occur in a patient who has
discontinued:
*A.* Smoking
*B.* Omeprazole
*C.* Fluoxetine
*D.* Warfarin
*E.* Gentamicin - ✔ *A.* Smoking
JJ is a 65 yom who comes to the clinic today for his annual visit. While reviewing his
records you discover he has had 5 COPD exacerbations requiring hospitalization since
his last visit a year ago. The most recent event occurred two months ago. Spirometry
reveals a FEV1 of 29%. How should you classify this patient's COPD?
*A.* Group A
*B.* Group B
*C.* Group C
*D.* Group D - ✔ C, D (He didn't specify the the mMRC nor the CAT...)(I'm sure he was
going for D, but not sure)
A PDE-4 inhibitor is recommended as third choice in which of the following COPD
groups?
*A.* Group A
*B.* Group B
*C.* Group C
*D.* Group D - ✔ *C.* Group C (Slide 98)
Which of the following medications is recommended as third choice in all COPD
classes?
*A.* Ipratropium
*B.* Theophylline
*C.* Albuterol
*D.* Anoro Ellipta
*E.* Roflumilast - ✔ *B.* Theophylline
